Website News and Research

RSS

Health advice on NHS website saves £44 million per year

The latest study has shown that as more people self diagnose using the NHS Choices website, Britain’s national healthcare service saves millions of pounds every year. The website was launched three years ago. Last year more than 100 million visits were recorded at the site which offers patients a quick reference guide to illnesses, symptoms, diagnosis and treatment. Overall, there was a 10% increase in the number of visits to the website in 2010 compared to 2009. Some 19 million people logged on to NHS Choices for information on swine flu.

9 Nov 2010

Semafore's SF1126 for B-cell chronic lymphocytic leukemia granted FDA orphan drug designation

Semafore Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the Company's SF1126 product candidate for the treatment of B-cell chronic lymphocytic leukemia (CLL). In April 2010, the Company initiated an expansion of its ongoing Phase I clinical study into this disease setting. SF1126 is a novel peptidic prodrug that converts to LY294002, one of the most widely studied small molecule inhibitors of both phosphatidylinositol 3-kinase (PI3K) and mammalian target of rapamycin (mTOR).

9 Nov 2010

Tyco reports revenue of $4.5 billion for fourth quarter 2010

Tyco International Ltd. today reported $0.55 in diluted earnings per share (EPS) from continuing operations for the fiscal fourth quarter of 2010 and diluted EPS from continuing operations before special items of $0.74 per share. Revenue in the quarter was $4.5 billion with organic revenue growth of 2% year-over-year. Cash from operating activities was $963 million and free cash flow was $598 million. These amounts included $39 million of cash outflows related to restructuring activities and acquisition-related costs.

9 Nov 2010

Angiotech reports $59.0 million total revenue for third quarter 2010

Angiotech Pharmaceuticals, Inc. today announced that it had released its financial results for the third quarter ended September 30, 2010.

9 Nov 2010

Seattle Genetics, Millennium to feature SGN-35 in two oral presentations at ASH Annual Meeting

Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited today announced that brentuximab vedotin (SGN-35) will be featured in two oral presentations at the 52nd American Society of Hematology (ASH) Annual Meeting and Exposition being held December 4-7, 2010 in Orlando, FL.

9 Nov 2010

Medisafe 1 website highlights ways to prevent incorrect medications

Medisafe 1 Technologies Corp. a developer of patented technologies that physically prevent the unauthorized administration of prescription medications, announced today that the company has uploaded a product presentation on the company's new website.

9 Nov 2010

Excess levels of TNF immune signaling protein key factor in AD

Three new studies provide converging evidence pointing to a new therapeutic target in Alzheimer's Disease(AD). These studies, from independent academic centers in the U.S., England, and China, point to excess levels of a protein called TNF as a key factor in AD. TNF is an immune signaling protein that regulates both inflammation and neuronal communication in the brain.

8 Nov 2010

Cadence offers $85 million shares of common stock in public offering

Cadence Pharmaceuticals, Inc. today announced that it is offering to sell $85 million worth of shares of its common stock in an underwritten public offering.

8 Nov 2010

Teva hosts Respiratory Opportunity Meeting for financial community

Teva Pharmaceutical Industries Ltd. today hosted its Respiratory Opportunity Meeting for the financial community in New York, featuring in-depth presentations on Teva's current and future respiratory growth strategy.

8 Nov 2010

Tomophase to commercialize OCT Imaging System for pulmonary applications with QTDP award

Tomophase Corporation, a leading developer of minimally invasive optical coherence tomography (OCT) tissue imaging devices, announced that it has received an award from the Departments of the Treasury and Health and Human Services for the Qualifying Therapeutic Discovery Project (QTDP.)

8 Nov 2010

EpiCept to receive $1.9 million in net proceeds

EpiCept Corporation announced today that it has entered into definitive agreements for the purchase of approximately 3.3 million shares of its common stock at $0.61 per share, and five-year warrants to purchase up to approximately 1.3 million shares of common stock at an exercise price of $0.56 per share, exercisable immediately.

8 Nov 2010

Provectus presents PV-10 Phase 2 clinical trial data for metastatic melanoma at Sydney Congress

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, presented positive preliminary data from fully monitored study data for the entire study population of 80 subjects in its Phase 2 clinical trial of PV-10 for metastatic melanoma.

8 Nov 2010

Research Roundup: Basing insurance on results, not cost; Americans skeptical of public health efforts; seniors' comprehensive care

Copayment Reductions Generate Greater Medication Adherence In Targeted Patients. As health care costs have increased, some patients have sought to save money by cutting down on their medications.

8 Nov 2010

Frequent long-term use of cell phones may increase cancer risk

Public health concerns have been raised today about the safety of being exposed to radiofrequency (RF) radiation emitted from cell phones. A report released by the Ontario Agency for Health Protection and Promotion (OAHPP) in September 2010 was one of the studies cited as providing evidence that frequent long-term use of cell phones may be associated with an increased risk of cancer.

4 Nov 2010

Affymetrix to contribute genotyping data to 1000 Genomes Project

Affymetrix, Inc. today announced that it will contribute genotyping data for a large set of validated rare and common genomic variants to the 1000 Genomes Project. This powerful data consists of genotyping information from more than 2 million single nucleotide polymorphisms (SNPs), and insertions/deletions (indels), many of which were not previously available from any source.

4 Nov 2010

AAPC launches beta version of Health Plan Policy Search Tool

AAPC has launched the beta version of its Health Plan Policy Search Tool giving providers access to more than 500 local and national health plans. This online search tool retrieves provider manuals, policies, physician credentialing and Medicare/Medicaid eligibility through an easy to use online tool. Users can now quickly find vital information instead of spending hours searching for the same information on each health plans website.

4 Nov 2010

Revolutions Medical announces completion of designs for 5ml and 10ml fixed needle RevVac Safety Syringes

Revolutions Medical Corporation announced today that due to the launch of its 3ml RevVac Safety SyringeTM during the Medica show in Dusseldorf, Germany and the enormous interest that the launch has received from healthcare professionals and corporations in Europe, the company will host an additional reception in London on Saturday, November 20th from 7:30 PM - 9:30 PM at the Landmark Hotel, Tower Suite.

3 Nov 2010

Safeguard Scientifics third quarter aggregate revenue of partner companies increases 73% to $109.6 million

Safeguard Scientifics, Inc., a holding company that provides growth capital for entrepreneurial and innovative life sciences and technology companies, today announced that aggregate revenue of its partner companies for the three months ended September 30, 2010 was $109.6 million, up 73% from $63.4 million for the same partner companies in the same period of 2009.

3 Nov 2010

Veterans deserve best health care coverage

The nation pauses to honor its veterans on November 11 for their patriotism, love of country, and willingness to serve and sacrifice for the common good. Naturally, we want our veterans to be taken care of, especially when it comes to their health. Those who have served their country through the United States military have several options when it comes to their health care coverage.

3 Nov 2010

Study reveals positive correlation between specialty nursing certification and workplace empowerment

Building on the body of evidence supporting a link between specialty nursing certification and workplace empowerment, a new study documents a positive association between nurses' perceptions of workplace empowerment and the proportion of nurses with specialty certification in hospital units.

3 Nov 2010

Website News and Research

Health advice on NHS website saves £44 million per year

Semafore's SF1126 for B-cell chronic lymphocytic leukemia granted FDA orphan drug designation

Tyco reports revenue of $4.5 billion for fourth quarter 2010

Angiotech reports $59.0 million total revenue for third quarter 2010

Seattle Genetics, Millennium to feature SGN-35 in two oral presentations at ASH Annual Meeting

Medisafe 1 website highlights ways to prevent incorrect medications

Excess levels of TNF immune signaling protein key factor in AD

Cadence offers $85 million shares of common stock in public offering

Teva hosts Respiratory Opportunity Meeting for financial community

Tomophase to commercialize OCT Imaging System for pulmonary applications with QTDP award

EpiCept to receive $1.9 million in net proceeds

Provectus presents PV-10 Phase 2 clinical trial data for metastatic melanoma at Sydney Congress

Research Roundup: Basing insurance on results, not cost; Americans skeptical of public health efforts; seniors' comprehensive care

Frequent long-term use of cell phones may increase cancer risk

Affymetrix to contribute genotyping data to 1000 Genomes Project

AAPC launches beta version of Health Plan Policy Search Tool

Revolutions Medical announces completion of designs for 5ml and 10ml fixed needle RevVac Safety Syringes

Safeguard Scientifics third quarter aggregate revenue of partner companies increases 73% to $109.6 million

Veterans deserve best health care coverage

Study reveals positive correlation between specialty nursing certification and workplace empowerment

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News